These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8572471)

  • 21. The dysplastic nevus syndrome.
    Krause SE
    J Ark Med Soc; 1984 Jan; 80(8):371-2. PubMed ID: 6229523
    [No Abstract]   [Full Text] [Related]  

  • 22. From the National Institutes of Health. Precursors to malignant melanoma.
    Am J Dermatopathol; 1984; 6 Suppl():169-74. PubMed ID: 6549368
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
    Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDKN2A (INK4A-ARF) mutation analysis to distinguish cutaneous melanoma metastasis from a second primary melanoma.
    Blokx WA; Lesterhuis WJ; Andriessen MP; Verdijk MA; Punt CJ; Ligtenberg MJ
    Am J Surg Pathol; 2007 Apr; 31(4):637-41. PubMed ID: 17414113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.
    Mössner R; Anders N; König IR; Krüger U; Schmidt D; Berking C; Ziegler A; Brockmöller J; Kaiser R; Volkenandt M; Westphal GA; Reich K
    Arch Dermatol Res; 2007 Jan; 298(8):371-9. PubMed ID: 17072629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis and staging in melanoma.
    Garrison M; Nathanson L
    Semin Oncol; 1996 Dec; 23(6):725-33. PubMed ID: 8970594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of familial aggregation of three melanoma risk factors: great number of naevi, light phototype and high degree of sun exposure.
    Briollais L; Chompret A; Guilloud-Bataille M; Bressac-de Paillerets B; Avril MF; Demenais F
    Int J Epidemiol; 2000 Jun; 29(3):408-15. PubMed ID: 10869311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic pathways to melanoma tumorigenesis.
    Hussein MR
    J Clin Pathol; 2004 Aug; 57(8):797-801. PubMed ID: 15280398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant melanoma, Breslow thickness and public education campaigns.
    Bucchi L; Serafini M; Crisanti E; Stanganelli I; Rafanelli S
    Br J Dermatol; 1992 Feb; 126(2):205-6. PubMed ID: 1536794
    [No Abstract]   [Full Text] [Related]  

  • 30. Bcl2 and Bax expression in naevi and melanomas and their relation to ploidy status and proliferation.
    Korabiowska M; Brinck U; Ruschenburg I; Schlott T; Droese M; Stachura J
    Pol J Pathol; 1999; 50(1):17-21. PubMed ID: 10412270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Be on the lookout for skin cancer.
    Lemanna L
    Am J Nurs; 1996 Aug; 96(8):16A-16D. PubMed ID: 8712231
    [No Abstract]   [Full Text] [Related]  

  • 32. [Remarks on familial melanoma].
    Korting GW
    Hautarzt; 1985 Apr; 36(4):242-3. PubMed ID: 3997523
    [No Abstract]   [Full Text] [Related]  

  • 33. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
    Fisher NM; Schaffer JV; Berwick M; Bolognia JL
    J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification of the hereditary variants of skin melanoma].
    Kazubskaia TP; Kozlova VM; Musatov VK; Mikhaĭlovskiĭ AV; Shabanov MA; Trofimov EI; Sel'chuk VIu; Gar'kavtseva RF
    Genetika; 2004 Jan; 40(1):88-96. PubMed ID: 15027204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of malignant melanoma arising from an acquired agminated melanocytic naevus.
    Corradin MT; Alaibac M; Fortina AB
    Acta Derm Venereol; 2007; 87(5):432-3. PubMed ID: 17721654
    [No Abstract]   [Full Text] [Related]  

  • 36. [Multiple primary melanoma and familial melanoma. Risk evaluation and screening tests. How to evaluate the risk of developing a second melanoma? In what family? Should screening methods be implemented? Which ones and why?].
    Grange F
    Ann Dermatol Venereol; 1995; 122(5):365-71. PubMed ID: 8572480
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.
    Nagore E; Montoro A; García-Casado Z; Botella-Estrada R; Insa A; Lluch A; López-Guerrero JA; Guillén C
    Melanoma Res; 2009 Aug; 19(4):211-4. PubMed ID: 19571771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neonatal melanoma arising in a giant congenital nevus].
    Benoit-Durafour F; Michel JL; Godard W; Chalencon V; Marzzocchi C; Chalencon F; Cambazard F
    Ann Dermatol Venereol; 1999 Nov; 126(11):813-6. PubMed ID: 10612859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desmoplastic melanoma: a diagnostic trap for the unwary.
    McCarthy SW; Scolyer RA; Palmer AA
    Pathology; 2004 Oct; 36(5):445-51. PubMed ID: 15370114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.